Pulmonary hypertension is a severe cardiovascular disorder characterized by abnormally elevated pulmonary arterial pressure. The disease often progresses insidiously and is associated with a poor prognosis, significantly impairing patients’ exercise capacity and quality of life.Riociguat tablets, as a novel targeted therapeutic agent, offer a new treatment option for patients with chronic...

DengyueMed Report: China's National Medical Products Administration has approved a milestone antitumor new drug—BaiZeAn (Tislelizumab Injection)—for the treatment of various advanced solid tumors, including non-small cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), and hepatocellular carcinoma. This breakthrough advancement marks a key step in China's...